Amarin Corp Plc (AMRN)

[MedResCollab]

Massulo, I’m afraid you’ve missed the point completely. The only rationale given by that physician to take 2 g/d Vascepa for at-risk patients is because 4 g/d is currently too expensive. And, presumably, because telling people to turn to third-party tested supplements that show exceptional TOTOX scores and accurate or better levels of stated API (EPA) to get their 4 g/d of EPA would not benefit the company they are invested in. That is deplorable.

Regards,
-MRC